Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
13 studies found for:    Diindolylmethane
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Diindolylmethane in Healthy Volunteers
Condition: Healthy, no Evidence of Disease
Intervention: Drug: oral microencapsulated diindolylmethane
2 Active, not recruiting Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Drug: B-Dim;   Procedure: Radical Prosatectomy
3 Withdrawn Oral Microencapsulated Diindolylmethane in Treating Patients With Stage II-III Triple Negative, Androgen Receptor Positive Breast Cancer Who Have Undergone Chemotherapy and Surgery
Condition: Breast Cancer Female
Interventions: Drug: oral microencapsulated diindolylmethane;   Other: laboratory biomarker analysis
4 Completed Diindolylmethane in Preventing Cancer in Healthy Volunteers
Condition: Healthy, no Evidence of Disease
Interventions: Drug: diindolylmethane;   Other: placebo;   Other: pharmacological study;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
5 Unknown  Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
Condition: Cervical Dysplasia
Intervention: Drug: diindolylmethane (DIM)
6 Completed Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Conditions: Adenocarcinoma of the Prostate;   Prostate Cancer;   Stage I Prostate Cancer;   Stage II Prostate Cancer
Interventions: Drug: diindolylmethane;   Drug: placebo;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: pharmacological study
7 Active, not recruiting Diindolylmethane in Treating Patients With Breast Cancer
Conditions: Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Dietary Supplement: diindolylmethane;   Dietary Supplement: placebo
8 Unknown  The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Condition: Breast Cancer
Intervention: Dietary Supplement: Diindolylmethane (DIM)
9 Completed Diindolylmethane in Treating Patients With Abnormal Cervical Cells
Conditions: Cervical Cancer;   Precancerous Condition
Interventions: Drug: oral microencapsulated diindolylmethane;   Genetic: polymerase chain reaction;   Other: cervical Papanicolaou test;   Other: cytology specimen collection procedure;   Procedure: colposcopic biopsy
10 Completed Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy
Condition: Prostate Cancer
Intervention: Drug: BR-DIM
11 Terminated New Therapy of Laryngeal Papilloma In Children
Condition: Papilloma
Interventions: Dietary Supplement: diindolylmethane (DIM);   Device: 585 nm pulsed dye laser
12 Terminated DIM as a Treatment for Thyroid Disease
Condition: Proliferative Thyroid Disease
Intervention: Dietary Supplement: Diindolylmethane (DIM)
13 Not yet recruiting A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers
Conditions: BRCA1 Gene Mutation;   BRCA2 Gene Mutation
Intervention: Dietary Supplement: DIM-Avail 100mg

Indicates status has not been verified in more than two years